Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation
暂无分享,去创建一个
F. Bertucci | P. Viens | G. Houvenaeghel | V. Bardou | J. Jacquemier | D. Maraninchi | J. Camerlo | M. Portier | A. Braud | M. Begue | G. Gravis